You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The commission plans to bar Bio-Rad from importing certain single-cell products, potentially including the ddSeq Single-Cell Isolator and ddSeq cartridges.
In Nature this week: new study of the Wuhan coronavirus suggests bats as the source of the outbreak, bioinformatic approach to identify cancer driver genes, and more.
In Genome Biology this week: computational strategy for clustering single cells, motivation for a Deep Genome Project for mice, and more.
The firm, cofounded by several Harvard University researchers, is commercializing a single-cell spatial transcriptomics technology called MERFISH.
Researchers found sub-chromosomal aneuploidy, DNA damage pathway changes, and other somatic changes in breast cells from BRCA2 mutation carriers.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.
10x Genomics sued Harvard University and 1CellBio, a competing single-cell technology firm, in 2018 over licenses for patents granted to both companies.
Researchers have identified immune cell gene expression signatures that could one day be developed into tests to predict response to treatment.
Blood and skin cell transcriptomes revealed a JAK-STAT signaling and human herpesvirus targets in an individual with refractory drug-induced hypersensitivity syndrome.
In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.
AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.
Time magazine looks into how liquid biopsies are changing cancer care.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.